Our Commitment to Safety and Transparency as We Study Our Investigational COVID-19 Vaccine Candidate
Learn More
Photos, Videos & Infographics
August 25, 2017
Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD) affect 16.5 million and 10 million Americans, respectively. Learn more about CAD and PAD and whether you could be at risk.
Media Center
October 14, 2016
We’re proud to be named to the Best Companies for Working Moms list by Working Mother magazine. But why were we? Hear the real scoop from 10 Johnson & Johnson working moms!
More From J&J
A preclinical study just published in Nature shows that the company's investigational vaccine has shown positive early data for eliciting an immune response against SARS-CoV-2, the virus that causes COVID-19. We share more about the findings from the recent preclinical study, along with other up-to-date information about the potential vaccine candidate.
On the latest episode of "The Road to a Vaccine," host Lisa Ling delves into the effects of the pandemic on kids. We sat down with one of the guests, Vikram Patel, a professor at Harvard Medical School, to find out the most pressing questions on his mind.
Think you are up to speed on the novel coronavirus? Take this quiz to test your virus knowledge.
